Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P06889 (
Mol
)
630,302
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
In order to investigate the mechanism controlling
gamma-glutamyltransferase
(
GGT
) gene expression in adult and fetal rat tissues, as well as in H5-6 and Fao hepatoma cells, the relationship between DNA methylation and
GGT
expression was studied. Southern blot analysis of genomic DNA digested with MspI and HpaII showed that highly methylated DNA patterns observed especially in adult liver, heart and Fao cells as well as in fetal kidney, pancreas, lung and heart correlate well with low
GGT
activity determined in these tissues. In contrast, hypomethylated
GGT
DNA was found in fetal liver, adult kidney and lung, the tissues highly expressing
GGT
activity. So, observed developmental- and tissue-specific changes in the
GGT
gene methylation seem to play an important role in the control of
GGT
gene transcription.
Biochem
Mol
Biol Int 1995 Jun
PMID:Developmental- and tissue-specific DNA methylation patterns and expression of rat gamma-glutamyltransferase. 766 29
To clarify the role of glutathione (GSH), an antioxidative substance, and its association with the gastric mucosal defense mechanism, we examined the gastric mucosal GSH and GSH-dependent enzymes in gastric ulcer patients. The subjects of this study were 10 patients with active ulcer on the lesser curvature side in the lower part of the gastric body and 11 normal controls. At the time of gastric endoscopy, gastric mucosal specimens were obtained by routine forceps biopsy from a site several millimeters apart from the ulcer margin, and these specimens were used for measurement of GSH, glutathione peroxidase (GSH-Px), glutathione-S transferase (GST) and
gamma-glutamyl transpeptidase
(
gamma-GTP
). The GSH level and the GSH-Px and GST activities in the patients with gastric ulcer were lower than those in the control group. The GSH-Px activity at the healed stage after treatment was increased compared with the pre-treatment value, while the GSH level was not markedly increased and the GST and
gamma-GTP
activities were similar to the pre-treatment value. The GSH level and GSH-Px activity remained decreased in the non-responder group. These results suggest that gastric mucosal GSH and GSH-dependent enzymes are closely related to the etiology and course of gastric ulcer.
Res Commun
Mol
Pathol Pharmacol 1995 May
PMID:Changes in glutathione in gastric mucosa of gastric ulcer patients. 767 Aug 48
The effect of sodium pentosan polysulphate (SPP) was investigated in calcium oxalate stone forming rats with respect to the urinary excretion of certain risk factors and enzymes. Calcium oxalate stones were induced by feeding 3% w/w sodium glycollate to the rats. Urinary calcium, oxalate, phosphorus and uric acid levels were increased in stone formers. In contrast magnesium excretion was low in this group. SPP treatment lowered oxalate and calcium levels in both controls and experimental animals. Magnesium levels were increased moderately. Increased excretion of urinary enzymes--LDH, alkaline phosphatase,
gamma-GT
and beta glucuronidase--in calculogenic rats indicates membranuria and damage to proximal tubules during stone formation. Decreased pyrophosphatase activity was observed in glycollate fed rats. SPP treatment decreased the excretion of the above enzymes in the treated groups. Stone formers exhibited decreased LAP and fibrinolytic (urokinase) activities. SPP being associated with fibrinolytic properties, increased the activities of the above two enzymes to that of control levels in calculogenic rats.
Biochem
Mol
Biol Int 1993 Feb
PMID:Alterations in some risk factors and urinary enzymes in urolithiatic rats treated with sodium pentosan polysulphate. 768 93
Brain capillaries contain a great variety of membrane proteins involved in the transport of hydrophilic nutrients or in the reception of hormonal signals. The use of Triton X-114 fractionation to purify membrane proteins according to their degree of hydrophobicity was investigated. Analysis by polyacrylamide gel electrophoresis showed a distinct polypeptide composition for each fraction. Most of the proteins (68%) were solubilized by Triton X-114 and, of these proteins, the majority (74%) was found in the detergent-poor phase. Alkaline phosphatase which possesses a glycosyl-phosphatidylinositol anchor partitioned in the pellet of insoluble proteins where it was enriched 2.3-fold. In contrast,
gamma-glutamyltranspeptidase
, the GLUT1 glucose transporter and P-glycoprotein, three integral membrane proteins, and p21ras and a 42 kDa G protein alpha subunit, both covalently modified by lipids, were efficiently solubilized and fractionated in the detergent-rich fraction where they were enriched 3.5-, 4.8-, 4.4-, 4.5- and 4.7-fold, respectively. Triton X-114 fractionation could therefore be used as a first step in the purification of many blood-brain barrier membrane proteins.
Biochem
Mol
Biol Int 1994 Dec
PMID:Extraction of brain capillary membrane proteins using Triton X-114. 769 79
The activity of
gamma-glutamyl transpeptidase
(
GGT
) and the sialic acid (SA) content were found to be specific in five brain regions of 7- and 50-day-old rats. While a low
GGT
activity was accompanied by high sialylation in the whole brain a high
GGT
activity and low sialylation were observed in kidney and pancreas. Similar findings were obtained for some brain regions investigated. However, the developmental differences were not characterized by such relationship. Concanavalin A affinity chromatography of
GGT
from brain of 7- and 50-day-old rats revealed no remarkable changes in
GGT
sialylation although the enzyme activity is almost 3 times higher in brain membranes of the older group. It can be concluded that in spite of an apparent relationship between
GGT
activity and membrane sialylation, the amount of SA linked to the
GGT
molecule is not related to differences in enzyme activity.
Biochem
Mol
Biol Int 1994 Dec
PMID:Relationship between gamma-glutamyl transpeptidase activity and sialic acid content in some organs and brain regions of the developing rat. 769 86
Aberrant crypt foci (ACF) are putative preneoplastic lesions that develop after treatment of animals with colon carcinogens, including cooked-meat heterocyclic amines such as 2-amino-3-methylimidazo[4,5-f]quinoline (IQ). Male F344 rats given IQ by gavage on alternating days for 2 wk (130 mg/kg body weight) and killed 12 wk after the final carcinogen dose had an average of 4.4 ACF/colon and an average of 3.2 crypts/focus. The DNA from these ACF was amplified by the polymerase chain reaction and analyzed by 3'-primer mismatch and direct sequencing methods for mutations in the Ki-ras proto-oncogene. Of the 37 IQ-induced ACF screened, three contained a
GGT
-->GAT mutation in codon 12 and one contained a GGC-->GCC mutation in codon 13. The approximately 11% frequency of mutation in IQ-induced ACF is within the range of previous ACF studies of azoxymethane, which reported a 7-37% incidence of Ki-ras mutation. These findings suggest that for both compounds, ras mutations occur during early stages of colorectal tumorigenesis. However, while ras mutations can be detected with increasing frequency in azoxymethane-induced adenomas and carcinomas, they are reportedly absent in IQ-induced colon tumors. Thus, for IQ and related compounds additional factors (possibly increased cell proliferation) may be important in the later stages of colorectal tumorigenesis.
Mol
Carcinog 1995 Apr
PMID:Evidence for ras gene mutation in 2-amino-3-methylimidazo[4,5-f]quinoline-induced colonic aberrant crypts in the rat. 772 39
We have used exonuclease III and DNase I protection assays to study proteins which bind to potentially regulatory elements located in the 5'-flanking region of the
gamma-glutamyl transpeptidase
gene. With both liver and kidney nuclear extracts, exonuclease III barriers were located at -566 in the coding strand and at -585 in the noncoding strand, and footprints were found from -595 to -566 and from -600 to -562, respectively. When the DNA was methylated in the CG dinucleotides, the exonuclease III barriers disappeared and the footprints were greatly reduced. The transcription factor Sp1 bound to this DNA region but did not seem to be involved in the binding activity. Since the
gamma-glutamyl transpeptidase
presents different levels of methylation in liver and kidney, associated with different levels of expression, these results suggest that the binding activity could play a role in the control of the expression of the
gamma-glutamyl transpeptidase
gene in liver and kidney.
Biochem
Mol
Biol Int 1995 Jan
PMID:Effect of DNA methylation on protein-DNA interactions upstream of the gamma-glutamyl transpeptidase gene. 773 35
Liver homogenate glutathione (GSH) content, lipid peroxide levels and the activities of GSH metabolizing enzymes were studied in rats after 24 hours of galactosamine (GalN) treatment. Lipid peroxide levels increased whereas hepatic GSH content was decreased significantly. On the other hand, hepatic gamma-glutamyl cysteine synthetase activity was unaffected by GalN administration but
gamma-glutamyl transpeptidase
activity increased.
Res Commun
Mol
Pathol Pharmacol 1995 Feb
PMID:Hepatic gamma-glutamyl cysteine synthetase and gamma-glutamyl transpeptidase activities in galactosamine-treated rats. 774 60
Cells in most culture media use cystine as the primary source of the cysteine precursor needed for glutathione (GSH) synthesis. As a result, GSH levels in many cultured cells may be limited by the rate of uptake of cystine into cells. We have shown that incubation with extracellular GSH can result in the reaction of GSH with cystine to generate cysteine, and that bovine pulmonary artery endothelial cells and lung type II epithelial cells transported cysteine more efficiently than cysteine. Cysteine transport was not affected by the presence of GSH. In cells incubated with GSH in RPMI-1640 there was a cystine-dependent increase in intracellular GSH levels. The increases in GSH were not prevented by the presence of acivicin, an inhibitor of the
gamma-glutamyl transpeptidase
reaction. Incubation with oxidized glutathione (GSSG) did not result in significant increases in intracellular GSH levels. We conclude that a primary mechanism by which extracellular GSH may increase intracellular GSH levels in cultured cells is by reducing cystine to cysteine, which is then rapidly transported and used as a substrate for intracellular GSH synthesis.
Am J Respir Cell
Mol
Biol 1995 Jun
PMID:Mechanisms of use of extracellular glutathione by lung epithelial cells and pulmonary artery endothelial cells. 776 29
The impact of type 1 diabetes mellitus on liver
gamma-glutamyltranspeptidase
, a premalignant marker, was studied. Diabetes was induced in male Sprague Dawley and Fischer 344 rats by administration of Streptozotocin, which produced a stable and moderately severe diabetic state. In liver homogenates,
gamma-glutamyltranspeptidase
was increased over control levels: 1.2, 8.1 and 13.2 fold in Sprague-Dawley rats; 4.8, 58.4 and 84.7 fold in Fischer 344 rats; at 1, 3 and 6 weeks following Streptozotocin treatment. In plasma membranes isolated from the livers of Fischer 344 rats,
gamma-glutamyltranspeptidase
was increased over control levels: 5.6, 75 and 127 fold at weeks 1, 3 and 6 following Streptozotocin treatment. The relative specific activity of 5'-nucleotidase was found to be similar: 9-14, indicating comparable degrees of plasma membrane purity. Plasma glutamate-pyruvate transaminase levels were minimally and similarly affected at all time points indicating lack of association of increasing
gamma-glutamyltranspeptidase
activity with overt liver damage. Thyroid hormone replacement, with both T3 (0.6 micrograms/Kg) once a day and T4 (6.0 micrograms/kg) twice a day for three days elicited a further 30% increment in enzyme activity. Insulin replacement (20-40 units/200 g body weight) twice a day for five days reduced enzyme activity 51% at week 6. This was associated with an increase in
gamma-glutamyltranspeptidase
in the plasma from 14 fold over control levels in the diabetic state at week 6 to 53 fold over control levels after insulin replacement at week 6. It is proposed that the diabetes-induced increase in
gamma-glutamyltranspeptidase
is reduced by an insulin-directed shedding of the enzyme into the plasma.
Mol
Cell Biochem 1994 Oct 26
PMID:The impact of type I diabetes on rat liver gamma-glutamyltranspeptidase. 786 3
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>